American Cancer Society
5
9M
5
0.05
- Areas of investment
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 5
- Lead investments
- 0
- Rounds per year
- 0.05
- Investments by industry
- Medical (3)
- Health Care (3)
- Health Diagnostics (1)
- Pharmaceutical (1)
- Life Science (1) Show 2 more
- Investments by region
- United States (5)
- Peak activity year
- 2022
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 47
- Group Appearance index
- 0.40
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Maia Oncology | 26 Nov 2023 | Health Care, Medical | Seed | 4M | United States, New York, New York |
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Lightworks , a Toronto, Canada-based company which specializes in AI control systems and infrastructure | Feb 17, 2026 | AI control systems, Infrastructure | - | 12000000 USD | Canada-based company which specializes in AI control systems and infrastructure, a Toronto |
| PocketHealth | Mar 20, 2024 | AI, Healthcare, Image Sharing Platform, Medical Image Exchange, Medical Image Sharing, Patient-Centric Platform | Growth stage | 33000000 USD | .svg) Toronto, Ontario |
| Avanti Software | Feb 24, 2022 | Cloud Platform, HCM Solution, Payroll & Benefits, People Management, Talent Acquisition, Workforce Management | - | 25000000 USD | Calgary, Alberta |
| Monsters Aliens Robots Zombies | Dec 2, 2021 | AI for VFX, Game Engine Technology, GPU Clusters, Technology, Visual Effects (VFX) | Early stage | 6500000 CAD | Toronto, Ontario |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.